The Royal Society of Chemistry (RSC) will hold its fifth High Throughput Medicinal Chemistry Conference on 12 May 2009 at Alderley Park in Cheshire, UK.
The event will explore technology-enabled drug discovery and new synthetic technologies, with a focus on medicinal chemistry - meaning this conference will benefit a range of organic and medicinal chemists.
Since its conception, the RSC's High Throughput Chemistry and New Technologies subject group has sought to highlight significant advances in the field, from the pharmaceutical, industrial and academic points of view.
Its fifth conference will focus on: CH activation, Pd coupling, flow chemistry, fragment-based drug discovery and drug discovery in academia.
This conference will include speeches from: Greg Fu, MIT; Steven Woodhead, Astex Therapeutics; Rob Maleczka, Michigan State University; Paul Watts, University of Hull; and John G Cumming, Astra Zeneca.
